Effects of Dienogest on breasts of women of reproductive age and women in menopausal transition: A cohort study
Observational
OA: bronze
CC0
⤵ 2 in-corpus citations
AI-generated summary
Dienogest was found to have no adverse effects on the breasts of women in reproductive age.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Synopsis Dienogest appears not to have any adverse breast effects on women of reproductive age.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (5)
- Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest<sup>®</sup>for continuous combined hormone replacement therapy in postmenopausal women via openalex
- Dienogest and the breast via openalex
- Effects of dienogest on breast : MCF cell line data via openalex
- Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study via openalex
- Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells via openalex
Cited by (3)
- Current Evidence and Emerging Directions in Endometriosis Pharmacotherapy: A Systematic Review of Recent Advances 2026
- Breast cancer is a threatening scenario resulting from the development of endometriosis and benign breast disease overlap syndrome: literature review 2025
- Long-term dienogest treatment in endometriosis: Consensus from Taiwanese experts 2024
Source provenance
- openalex
- last seen: 2026-05-14T06:22:01.966093+00:00
- pubmed
- last seen: 2026-10-08T21:40:13.912809+00:00
License: CC0
· commercial use OK